Empagliflozin does not affect left ventricular diastolic function in patients with type 2 diabetes mellitus and coronary artery disease: insight from the EMPA-HEART CardioLink-6 randomized clinical trial
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:59 |
|---|---|
| Enthalten in: |
Acta diabetologica - 59(2022), 4 vom: 21. Jan., Seite 575-578 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Rai, Archana [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| BKL: | |
|---|---|
| Themen: |
| Anmerkungen: |
© Springer-Verlag Italia S.r.l., part of Springer Nature 2022 |
|---|
| doi: |
10.1007/s00592-021-01823-6 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC2078228257 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC2078228257 | ||
| 003 | DE-627 | ||
| 005 | 20230511071627.0 | ||
| 007 | tu | ||
| 008 | 221220s2022 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00592-021-01823-6 |2 doi | |
| 035 | |a (DE-627)OLC2078228257 | ||
| 035 | |a (DE-He213)s00592-021-01823-6-p | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.00 |2 bkl | ||
| 100 | 1 | |a Rai, Archana |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Empagliflozin does not affect left ventricular diastolic function in patients with type 2 diabetes mellitus and coronary artery disease: insight from the EMPA-HEART CardioLink-6 randomized clinical trial |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a © Springer-Verlag Italia S.r.l., part of Springer Nature 2022 | ||
| 650 | 4 | |a Empagliflozin | |
| 650 | 4 | |a SGLT2 inhibitors | |
| 650 | 4 | |a Diabetes | |
| 650 | 4 | |a LV diastolic function | |
| 700 | 1 | |a Connelly, Kim A. |4 aut | |
| 700 | 1 | |a Verma, Subodh |4 aut | |
| 700 | 1 | |a Mazer, C. David |4 aut | |
| 700 | 1 | |a Teoh, Hwee |4 aut | |
| 700 | 1 | |a Ng, Ming-Yen |4 aut | |
| 700 | 1 | |a Roifman, Idan |4 aut | |
| 700 | 1 | |a Quan, Adrian |4 aut | |
| 700 | 1 | |a Pourafkari, Marina |4 aut | |
| 700 | 1 | |a Jimenez-Juan, Laura |4 aut | |
| 700 | 1 | |a Ramanan, Venkat |4 aut | |
| 700 | 1 | |a Ge, Yin |4 aut | |
| 700 | 1 | |a Deva, Djeven P. |4 aut | |
| 700 | 1 | |a Yan, Andrew T. |0 (orcid)0000-0002-2063-7485 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Acta diabetologica |d Springer Milan, 1991 |g 59(2022), 4 vom: 21. Jan., Seite 575-578 |w (DE-627)131035991 |w (DE-600)1097676-0 |w (DE-576)02804259X |x 0940-5429 |7 nnns |
| 773 | 1 | 8 | |g volume:59 |g year:2022 |g number:4 |g day:21 |g month:01 |g pages:575-578 |
| 856 | 4 | 1 | |u https://doi.org/10.1007/s00592-021-01823-6 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 936 | b | k | |a 44.00 |q VZ |
| 951 | |a AR | ||
| 952 | |d 59 |j 2022 |e 4 |b 21 |c 01 |h 575-578 | ||